Literature DB >> 6744682

A simple HPLC assay for urinary paracetamol metabolites and its use to characterize the C3H mouse as a model for paracetamol metabolism studies.

J Miners, J F Adams, D J Birkett.   

Abstract

A high performance liquid chromatographic (HPLC) assay for unchanged paracetamol and its glucuronide, sulphate, cysteine and mercapturic acid conjugates in the urine of man, mouse and rat is described. The method is simple, rapid and reproducible. The metabolite assay has been used to characterize the male C3H mouse, which shows sensitivity to paracetamol toxicity similar to man, as a model for paracetamol metabolism studies. In male C3H mice there was no evidence to suggest saturability of the glucuronidation pathway on increasing the paracetamol dose from 50 to 300 mg/kg. By contrast, the metabolic ratio and fractional excretion of both the sulphate and glutathione-derived conjugates decreased with increasing paracetamol dose. For animals administered a 200 mg/kg dose of paracetamol, pretreatment with phenobarbitone or 3-methylcholanthrene increased the fractional excretion and metabolic ratio of the glutathione-derived and glucuronic acid conjugates. Piperonyl butoxide pretreatment of animals administered the same dose of paracetamol inhibited glutathione and glucuronic acid conjugation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744682     DOI: 10.1111/j.1440-1681.1984.tb00258.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

1.  Perturbation of paracetamol urinary metabolic ratios by urine flow rate.

Authors:  J O Miners; N J Osborne; A L Tonkin; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Comparison of paracetamol metabolism in young adult and elderly males.

Authors:  J O Miners; R Penhall; R A Robson; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites.

Authors:  R H Rumble; M S Roberts; M J Denton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

4.  Paracetamol metabolism in pregnancy.

Authors:  J O Miners; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

5.  Interethnic differences in drug glucuronidation: a comparison of paracetamol metabolism in Caucasians and Chinese.

Authors:  N J Osborne; A L Tonkin; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

6.  Pharmacokinetic consequences and toxicologic implications of metyrapone-induced alterations of acetaminophen elimination in man.

Authors:  R E Galinsky; E B Nelson; D E Rollins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Bioavailability of paracetamol with/without caffeine in Egyptian patients with hepatitis C virus.

Authors:  Naglaa M El-Lakkany; Ahmed S Hendawy; Sayed H Seif El-Din; Ahmed A Ashour; Raafat Atta; Abdel-Aziz H Abdel-Aziz; Ahmed M Mansour; Sanaa S Botros
Journal:  Eur J Clin Pharmacol       Date:  2016-02-18       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.